I. Casado-Fariñas

Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma

P. Pérez-Segura, V. García-Barberán, Isabel Díaz-Millán, 2022, Therapeutic advances in medical oncology.

Lights and shadows in the diagnosis and surveillance of a young asymptomatic patient with Peutz-Jeghers syndrome.

I. Casado-Fariñas, L. Adán-Merino, M. Aldeguer-Martínez, 2016 .

Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas

P. Pérez-Segura, Hillary S Sloane, V. García-Barberán, 2022, Cancers.

Jessner’s lymphocytic infiltrate as a Koebner response to patch test

L. Condé‐Salazar, I. Casado-Fariñas, F. Heras‐Mendaza, 2007, Contact dermatitis.

Erythema multiforme‐like eruption due to an irritant contact dermatitis from a glyphosate pesticide

L. Condé‐Salazar, I. Casado-Fariñas, F. Heras‐Mendaza, 2008, Contact dermatitis.

[Symptomatic exaggerated placental site after first trimester abortion].

J. J. Hernández-Aguado, Jesús de la Fuente-Valero, I. Casado-Fariñas, 2015, Ginecologia y obstetricia de Mexico.

Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib

P. Pérez-Segura, M. Cabrera-Martín, V. García-Barberán, 2024, The oncologist.

Durable benefit and slowdown in tumor growth dynamics with erdafitinib in a FGFR3-TACC3 fusion-positive IDH-wild type glioblastoma

P. Pérez-Segura, R. Pérez-Alfayate, S. Cabezas-Camarero, 2024, Neuro-oncology advances.